Patient-Initiated Prostate Cancer Screening Among Older U.S. Men
Authors: Michael W. Drazer, Scott E. Eggener
Journal: Annals of Internal Medicine (2016)

Letters17 May 2016Patient-Initiated Prostate Cancer Screening Among Older U.S. MenMichael W. Drazer, MD and Scott E. Eggener, MDMichael W. Drazer, MDFrom The University of Chicago Medical Center, Chicago, Illinois.Search for more papers by this author and Scott E. Eggener, MDFrom The University of Chicago Medical Center, Chicago, Illinois.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L15-0619 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:We read the recent letter from Guo and He (1) with great interest and were particularly intrigued by their finding that patient-initiated screening increased in correlation with age. The authors limited their analysis to men aged 40 to 70 years for unclear reasons, especially because a large proportion of men older than 70 years are screened for prostate cancer. We recently reported that, in 2013, men aged 75 to 79 years were significantly more likely to be screened than men in their 50s and one third of men older than 75 years with less than 9 years ...References1. Guo F, He D. The roles of providers and patients in the overuse of prostate-specific antigen screening in the United States [Letter]. Ann Intern Med. 2015;163:650-1. [PMID: 26502132]. doi:10.7326/L15-5150 LinkGoogle Scholar2. Drazer MW, Huo D, Eggener SE. National prostate cancer screening rates after the 2012 US Preventive Services Task Force recommendation discouraging prostate-specific antigen-based screening. J Clin Oncol. 2015;33:2416-23. [PMID: 26056181] doi:10.1200/JCO.2015.61.6532 CrossrefMedlineGoogle Scholar3. Drazer MW, Prasad SM, Huo D, Schonberg MA, Dale W, Szmulewitz RZ, et al. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer. 2014;120:1491-8. [PMID: 24523016] doi:10.1002/cncr.28600 CrossrefMedlineGoogle Scholar4. Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120-34. [PMID: 22801674]. doi:10.7326/0003-4819-157-2-201207170-00459 LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From The University of Chicago Medical Center, Chicago, Illinois.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L15-0619. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Roles of Providers and Patients in the Overuse of Prostate-Specific Antigen Screening in the United States Fangjian Guo and Di He Patient-Initiated Prostate Cancer Screening Among Older U.S. Men Fangjian Guo Metrics Cited byMulti-Photonic behavior of Nb2O5 and its correlation with synthetic methods 17 May 2016Volume 164, Issue 10Page: 702-703KeywordsAntigensCancer screeningDecision makingDisclosureHealth surveysLife expectancyMotivationPatientsProstate cancer ePublished: 17 May 2016 Issue Published: 17 May 2016 Copyright & PermissionsCopyright © 2016 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...